JMPWA
KITE

JP Morgan Private Wealth Advisors’s Kite Pharma, Inc. KITE Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-366,638
Closed -$65.9M – 1350
2017
Q3 		$65.9M Sell
366,638
-1,055
-0.3% -$147K 0.47% 59
2017
Q2 		$38.1M Sell
367,693
-3,359
-0.9% -$274K 0.29% 93
2017
Q1 		$29.1M Sell
371,052
-19,367
-5% -$1.2M 0.23% 105
2016
Q4 		$17.5M Buy
390,419
+21,436
+6% +$1.05M 0.15% 139
2016
Q3 		$20.6M Buy
368,983
+648
+0.2% +$36.1K 0.19% 124
2016
Q2 		$18.4M Sell
368,335
-371,532
-50% -$18.3M 0.18% 130
2016
Q1 		$34M Buy
739,867
+372,034
+101% +$18M 0.32% 88
2015
Q4 		$22.7M Sell
367,833
-2,843
-0.8% -$200K 0.23% 113
2015
Q3 		$20.6M Sell
370,676
-1,451
-0.4% -$91.3K 0.26% 106
2015
Q2 		$22.7M Sell
372,127
-134,468
-27% -$7.67M 0.26% 109
2015
Q1 		$29.2M Sell
506,595
-222,670
-31% -$14.9M 0.33% 81
2014
Q4 		$42.1M Buy
+729,265
New +$30.7M 0.5% 58

JP Morgan Private Wealth Advisors's KITE Position: Q4 2017 in Review

JP Morgan Private Wealth Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 366,638 shares — an estimated $65.9M sold.

JP Morgan Private Wealth Advisors first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $65.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • JP Morgan Private Wealth Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 366,638 Kite Pharma, Inc. shares in Q4 2017, an estimated $65.9M.
  • JP Morgan Private Wealth Advisors first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • JP Morgan Private Wealth Advisors's Kite Pharma, Inc. position peaked at $65.9M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.